Greg Modic

Greg Modic currently serves as Senior Director of GI & Thyroid Marketing at Exelixis since October 2020. Prior to this role, Modic held various marketing positions including Director of Marketing at Veracyte, Inc. and Senior Director of Marketing at IGNYTA, Inc., where the focus was on the launch of entrectinib for ROS1 NSCLC. Modic's extensive experience at Genentech included Senior Product Manager roles in BioOncology and Hematology Marketing, as well as training positions for key products like Rituxan and ACTEMRA. Earlier career experience encompasses roles at Genzyme, Biogen Idec, and Eli Lilly & Co, where significant product launches took place, including Forteo and Strattera. Greg Modic holds a B.S. in Finance from Penn State University, earned in 2002.